Levi & Korsinsky notifies investors that it has commenced an investigation into Cano Health, Inc. (NYSE: CANO) concerning potential violations of the federal securities laws.
On November 17, 2023, UBS cut its rating of Cano Health to "Sell", citing the Company's deteriorating liquidity position. UBS opined that "elevated third-party medical expenses will have a sustained negative effect on the company's already challenged liquidity position." On this news, Cano's stock price fell 6.72%, to close at $7.63 per share on November 17, 2023.
If you suffered a loss on your Cano Health securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure





